Atypical Bacteria
Atypical bacteria (primarily Chlamydia and Mycoplasma) have been implicated in less than 10% of COPD exacerbations, although 1 study conducted in Turkey found that it was the sole causal agent in 16% of exacerbations and 1 of several causal agents in 6% of cases. In the most severe cases, Gram-positive or Gram-negative bacteria were also present. The presence of Gram-negative bacteria should be suspected in patients:
- with stage III disease
- who experience at least 3 or 4 infections per year
- with concurrent bronchiectasis (swollen, thickened, dilated bronchial tubes that are diagnosed with a CT scan)
Many exacerbations of COPD may not be precipitated by infection alone, and in those infectious exacerbations, frequently more than 1 organism may be the cause. As a result, treatment for infectious exacerbations is usually broad-spectrum.
Disclaimer: The articles on this web site are provided for
general information only and should not be used as a basis for diagnosis or
treatment. All exercises and information featured on this web site should only
be practised under the supervision of a qualified healthcare professional.
The goals of the Medical Sites Network are to provide people with meaningful information to make informed decisions about their health and health care.
The goals of the Medical Sites Network are to provide people with meaningful information to make informed decisions about their health and health care.
